MD2447F2 - Compozitie farmaceutica, utilizarea ei si metode de tratare a cefaleei, migrenei, greturilor si vomei - Google Patents

Compozitie farmaceutica, utilizarea ei si metode de tratare a cefaleei, migrenei, greturilor si vomei Download PDF

Info

Publication number
MD2447F2
MD2447F2 MDA20020139A MD20020139A MD2447F2 MD 2447 F2 MD2447 F2 MD 2447F2 MD A20020139 A MDA20020139 A MD A20020139A MD 20020139 A MD20020139 A MD 20020139A MD 2447 F2 MD2447 F2 MD 2447F2
Authority
MD
Moldova
Prior art keywords
sickness
vomiting
treatment
cephalalgia
migraine
Prior art date
Application number
MDA20020139A
Other languages
English (en)
Other versions
MD2447G2 (ro
MD20020139A (ro
Inventor
Alexander Mirimsky
Raphael Barkan
Original Assignee
Meditor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd filed Critical Meditor Pharmaceuticals Ltd
Publication of MD20020139A publication Critical patent/MD20020139A/ro
Publication of MD2447F2 publication Critical patent/MD2447F2/ro
Publication of MD2447G2 publication Critical patent/MD2447G2/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
MDA20020139A 2000-09-05 2001-08-30 Compoziţie farmaceutică, utilizarea ei şi metodă de tratare a cefaleei, migrenei, greţurilor şi vomei MD2447G2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
PCT/IL2001/000817 WO2002019961A2 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Publications (3)

Publication Number Publication Date
MD20020139A MD20020139A (ro) 2002-11-30
MD2447F2 true MD2447F2 (ro) 2004-05-31
MD2447G2 MD2447G2 (ro) 2005-12-31

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20020139A MD2447G2 (ro) 2000-09-05 2001-08-30 Compoziţie farmaceutică, utilizarea ei şi metodă de tratare a cefaleei, migrenei, greţurilor şi vomei

Country Status (21)

Country Link
US (2) US7148208B2 (ro)
EP (1) EP1315505B1 (ro)
JP (1) JP2004508311A (ro)
KR (1) KR100849999B1 (ro)
CN (1) CN100448439C (ro)
AT (1) ATE375797T1 (ro)
AU (2) AU8617801A (ro)
BR (1) BR0113698A (ro)
CA (1) CA2420410C (ro)
CY (1) CY1107270T1 (ro)
DE (1) DE60131004T2 (ro)
DK (1) DK1315505T3 (ro)
ES (1) ES2296792T3 (ro)
HU (1) HUP0302362A3 (ro)
IL (1) IL154456A (ro)
MD (1) MD2447G2 (ro)
MX (1) MXPA03001737A (ro)
NO (1) NO20031902L (ro)
NZ (1) NZ524903A (ro)
PT (1) PT1315505E (ro)
WO (1) WO2002019961A2 (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420410C (en) * 2000-09-05 2011-04-26 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions for headache, migraine, nausea and emesis
US20090186854A1 (en) * 2006-03-23 2009-07-23 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
EP2167050A1 (en) * 2007-06-13 2010-03-31 Meditor Pharmaceuticals Ltd. Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
WO1998013036A1 (en) * 1996-09-26 1998-04-02 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
EP1829539A3 (en) * 1996-11-05 2008-02-20 HEADEXPLORER ApS A method for treating tension-type headache
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
AU3511500A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
JP2003505427A (ja) * 1999-07-21 2003-02-12 オメロス コーポレイション 疼痛、炎症および軟骨分解の抑制のための溶液および方法
CA2420410C (en) * 2000-09-05 2011-04-26 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions for headache, migraine, nausea and emesis

Also Published As

Publication number Publication date
BR0113698A (pt) 2003-12-09
JP2004508311A (ja) 2004-03-18
NZ524903A (en) 2004-11-26
KR20030055257A (ko) 2003-07-02
WO2002019961A3 (en) 2002-08-15
CY1107270T1 (el) 2012-11-21
DE60131004D1 (de) 2007-11-29
AU2001286178B2 (en) 2006-09-14
MD2447G2 (ro) 2005-12-31
EP1315505A4 (en) 2006-02-22
CA2420410C (en) 2011-04-26
CA2420410A1 (en) 2002-03-14
IL154456A (en) 2013-05-30
US8673979B2 (en) 2014-03-18
HUP0302362A2 (hu) 2003-11-28
US20070088005A1 (en) 2007-04-19
MD20020139A (ro) 2002-11-30
PT1315505E (pt) 2008-01-28
DE60131004T2 (de) 2008-07-31
US7148208B2 (en) 2006-12-12
ATE375797T1 (de) 2007-11-15
MXPA03001737A (es) 2004-09-10
US20040006044A1 (en) 2004-01-08
HK1058009A1 (zh) 2004-04-30
CN1464788A (zh) 2003-12-31
KR100849999B1 (ko) 2008-08-01
ES2296792T3 (es) 2008-05-01
CN100448439C (zh) 2009-01-07
NO20031902D0 (no) 2003-04-28
EP1315505B1 (en) 2007-10-17
WO2002019961A2 (en) 2002-03-14
EP1315505A2 (en) 2003-06-04
DK1315505T3 (da) 2008-03-03
HUP0302362A3 (en) 2005-05-30
NO20031902L (no) 2003-06-09
AU8617801A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
MD2447F2 (ro) Compozitie farmaceutica, utilizarea ei si metode de tratare a cefaleei, migrenei, greturilor si vomei
JO2339B1 (en) Benzamidazole compounds
AP1739A (en) Azaindoles
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
GEP20094627B (en) High drug load tablet
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
WO2005056524A3 (en) Therapeutic agents useful for treating pain
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
WO2004004632A8 (en) Flavone derivatives as inhibitors of cyclin-dependent kinases
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2005030753A3 (en) Therapeutic agents useful for treating pain
GEP20043383B (en) Cell Adhesion-Inhibiting Antiinflammatory and Immune-Suppressive Compounds
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
IL149586A0 (en) Pyrimidine derivatives as selective inhibitors of cox-2
BG106155A (en) Novel derivatives and analogues of galanthamin
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
HK1053833A1 (zh) 取代苯基法呢基转移酶抑制剂
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
MX2007006635A (es) Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion.
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2001256727A1 (en) Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees